Cargando…

The Ultimate Goal of Curative Anti-Cancer Therapies: Inducing an Adaptive Anti-Tumor Immune Response

Detalles Bibliográficos
Autores principales:	Fridman, Wolf H., Teillaud, Jean-Luc, Sautès-Fridman, Catherine, Pagès, Franck, Galon, Jérôme, Zucman-Rossi, Jessica, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341952/ https://www.ncbi.nlm.nih.gov/pubmed/22566855 http://dx.doi.org/10.3389/fimmu.2011.00066

Ejemplares similares

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial watch: Dendritic cell-based interventions for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Trial watch: Peptide vaccines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Peptide vaccines in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2013)

The European Academy of Tumor Immunology: Bridging fields, continents and generations
por: Kroemer, Guido, et al.
Publicado: (2012)

Trial watch: Prognostic and predictive value of the immune infiltrate in cancer
por: Senovilla, Laura, et al.
Publicado: (2012)

Trial watch: Oncolytic viruses for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial watch: Monoclonal antibodies in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Peptide-based anticancer vaccines
por: Pol, Jonathan, et al.
Publicado: (2015)

Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014)

Trial Watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2014)

Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Trial watch: Dendritic cell-based interventions for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Trial watch: DNA vaccines for cancer therapy
por: Senovilla, Laura, et al.
Publicado: (2013)

Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial Watch: DNA vaccines for cancer therapy
por: Pol, Jonathan, et al.
Publicado: (2014)

The prognostic impact of anti-cancer immune response: a novel classification of cancer patients
por: Bindea, Gabriela, et al.
Publicado: (2011)

Presentation of Antigen in Immune Complexes Is Boosted by Soluble Bacterial Immunoglobulin Binding Proteins
por: Léonetti, Michel, et al.
Publicado: (1999)

Tumor microenvironment in NSCLC suppresses NK cells function
por: Cremer, Isabelle, et al.
Publicado: (2012)

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
por: Stoll, Gautier, et al.
Publicado: (2014)

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies
por: Stoll, Gautier, et al.
Publicado: (2015)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

Tumor Immunology, toward a Success Story?
por: Sautès-Fridman, Catherine
Publicado: (2015)

Characteristics of tertiary lymphoid structures in primary cancers
por: Goc, Jérémy, et al.
Publicado: (2013)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
por: Becht, Etienne, et al.
Publicado: (2015)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020)

Complement System: Promoter or Suppressor of Cancer Progression?
por: Revel, Margot, et al.
Publicado: (2020)

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
por: Bindea, Gabriela, et al.
Publicado: (2009)

Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models
por: Galand, Claire, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_296o05f7miq4qkfhkk57sdbf0e